Business Driver: Insulet (PODD) is one of the world's leading manufacturers of insulin pump systems. Its flagship product is the Omnipod system, a portable, tubeless insulin pump that continuously delivers insulin, eliminating the need for daily injections. The latest version, Omnipod 5, integrates with continuous glucose monitors like the Dexcom G6...
The Best Growth Stocks by Revenue & Profit
Rank | Stock | Price | Rev. Gr. | Dist. 52WH | Perf. 20D |
---|---|---|---|---|---|
WKN | Symbol | EPS Growth | Rel. Strength | |||
1 | Verisk Analytics | 278.09 $ | 26.37 % | 9.32 % | -3.45 % |
A0YA2M | VRSK | 88.86 % | 86 | |||
2 | Palomar Holdings | 130.13 $ | 40.22 % | 9.49 % | -0.24 % |
A2PHB6 | PLMR | 49.48 % | 96 | |||
3 | HCI Group | 137.14 $ | 49.16 % | 9.70 % | -1.56 % |
A1W02H | HCI | 199.39 % | 85 | |||
4 | Progressive | 259.68 $ | 22.67 % | 11.37 % | -6.44 % |
865496 | PGR | 198.70 % | 88 | |||
5 | Universal Technical Institute | 26.47 $ | 20.63 % | 13.39 % | -1.64 % |
590097 | UTI | 533.33 % | 96 | |||
6 | Halozyme Therapeutics | 56.53 $ | 21.35 % | 14.34 % | -7.15 % |
A0DLHS | HALO | 60.73 % | 92 | |||
7 | Insulet | 246.49 $ | 27.42 % | 14.84 % | -0.76 % |
A0MQX8 | PODD | 250.00 % | 92 | |||
8 | Interdigital | 192.19 $ | 28.53 % | 17.15 % | -9.55 % |
A0MWY3 | IDCC | 41.33 % | 98 | |||
9 | Tradeweb Markets | 122.34 $ | 29.44 % | 19.86 % | -8.22 % |
TW | 20.69 % | 84 | |||
10 | Catalyst Pharmaceuticals | 20.86 $ | 32.17 % | 20.27 % | -1.62 % |
A0LCUL | CPRX | 111.86 % | 90 | |||
Already a subscriber? Login






Insulet is a medical technology company focused on the development, manufacturing, and marketing of an insulin infusion system for people with insulin-dependent diabetes. The company exceeded earnings estimates for Q1, driven by the strong demand for its portable insulin pumps. The customer base already includes over 500,000 active users with...

Insulet (PODD) is regarded as the world's leading provider of tubeless insulin pumps and sees itself as the market leader in automated insulin delivery. Since April 28, Ashley McEvoy has taken over as CEO, bringing extensive experience from her previous leadership role in Johnson & Johnson's medical technology division. She emphasizes: "We are already...